Search Results - Dai, Wenbing, PhD

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts

    A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts by Chen, Binlong, MSc, Wang, Zhaoyang, MPharm, Sun, Jing, MPharm, Song, Qin, MSc, He, Bing, PhD, Zhang, Hua, PhD, Wang, Xueqing, PhD, Dai, Wenbing, PhD, Zhang, Qiang, PhD

    Published in Nanomedicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A nanomedicine based combination therapy based on QLPVM peptide functionalized liposomal tamoxifen and doxorubicin against Luminal A breast cancer

    A nanomedicine based combination therapy based on QLPVM peptide functionalized liposomal tamoxifen and doxorubicin against Luminal A breast cancer by Wang, Xiaoyou, MS, Chen, Xianhui, MS, Yang, Xiucong, MS, Gao, Wei, PhD, He, Bing, PhD, Dai, Wenbing, PhD, Zhang, Hua, PhD, Wang, Xueqing, PhD, Wang, Jiancheng, PhD, Zhang, Xuan, PhD, Dai, Zhifei, PhD, Zhang, Qiang, PhD

    Published in Nanomedicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature

    Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature by Yang, Tingyuan, PhD, Wang, Yiguang, PhD, Li, Zaiquan, PhD, Dai, Wenbing, PhD, Yin, Jie, PhD, Liang, Liang, MPharm, Ying, Xue, PhD, Zhou, Shufeng, MD, PhD, Wang, Jiancheng, PhD, Zhang, Xuan, PhD, Zhang, Qiang, PhD

    Published in Nanomedicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Peptide PHSCNK as an integrin α5 β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma

    Peptide PHSCNK as an integrin α5 β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma by Dai, Wenbing, PhD, Yang, Tingyuan, PhD, Wang, Yiguang, PhD, Wang, Xueqing, PhD, Wang, Jiancheng, PhD, Zhang, Xuan, PhD, Zhang, Qiang, PhD

    Published in Nanomedicine
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: